Biomarker can help health care assess severity of COVID-19

Researchers at Karolinska Institutet and the University of Gothenburg have identified a biomarker that could become an important tool for health care in assessing patients with acute COVID-19 infection. The researchers have studied interleukin (IL)-26, a signaling substance in the immune system, which has been shown to reflect the severity of the disease…
Source : Medical Xpress